DK592585A - Fremgangsmaade til fremstilling af oxetanoner - Google Patents

Fremgangsmaade til fremstilling af oxetanoner Download PDF

Info

Publication number
DK592585A
DK592585A DK592585A DK592585A DK592585A DK 592585 A DK592585 A DK 592585A DK 592585 A DK592585 A DK 592585A DK 592585 A DK592585 A DK 592585A DK 592585 A DK592585 A DK 592585A
Authority
DK
Denmark
Prior art keywords
formula see
see diagramm
oxetanones
manufacture
procedure
Prior art date
Application number
DK592585A
Other languages
English (en)
Other versions
DK592585D0 (da
DK168536B1 (da
Inventor
Pierre Barbier
Fernand Schneider
Ulrich Widmer
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of DK592585D0 publication Critical patent/DK592585D0/da
Publication of DK592585A publication Critical patent/DK592585A/da
Application granted granted Critical
Publication of DK168536B1 publication Critical patent/DK168536B1/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/02Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D305/10Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
    • C07D305/12Beta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
DK592585A 1984-12-21 1985-12-19 Fremgangsmåde til fremstilling af oxetanoner DK168536B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH610184 1984-12-21
CH610184 1984-12-21
CH406785 1985-09-19
CH406785 1985-09-19

Publications (3)

Publication Number Publication Date
DK592585D0 DK592585D0 (da) 1985-12-19
DK592585A true DK592585A (da) 1986-06-22
DK168536B1 DK168536B1 (da) 1994-04-18

Family

ID=25694557

Family Applications (1)

Application Number Title Priority Date Filing Date
DK592585A DK168536B1 (da) 1984-12-21 1985-12-19 Fremgangsmåde til fremstilling af oxetanoner

Country Status (11)

Country Link
US (1) US4983746A (da)
EP (1) EP0189577B1 (da)
CN (1) CN1010586B (da)
AT (1) ATE48600T1 (da)
AU (1) AU585555B2 (da)
CA (1) CA1328881C (da)
DE (1) DE3574700D1 (da)
DK (1) DK168536B1 (da)
IE (1) IE58917B1 (da)
NZ (1) NZ214567A (da)
PH (1) PH22445A (da)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA2035972C (en) * 1990-02-23 2006-07-11 Martin Karpf Process for the preparation of oxetanones
US5260310A (en) * 1990-02-26 1993-11-09 Hoffmann-La Roche Inc. Oxetanone compounds and pharmaceutical compositions containing them
PT1017408E (pt) * 1997-02-05 2005-07-29 Hoffmann La Roche Utilizacao de tetra-hidrolipstatina no tratamento de diabetes de tipo ii
GB9727131D0 (en) 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents
IL144045A0 (en) * 1999-10-29 2002-04-21 Mullins John Jason Gentry Oxetanone derivatives
EP1132389A1 (en) 2000-03-06 2001-09-12 Vernalis Research Limited New aza-indolyl derivatives for the treatment of obesity
WO2002009814A2 (en) 2000-07-28 2002-02-07 F. Hoffmann-La Roche Ag New use of lipase inhibitors
WO2002011719A2 (en) 2000-08-09 2002-02-14 F. Hoffmann-La Roche Ag Lipase inhibitors for the treatment of dyspepsia
US6900226B2 (en) 2000-09-06 2005-05-31 Hoffman-La Roche Inc. Neuropeptide Y antagonists
AU2002221670B2 (en) 2000-10-16 2006-11-02 F. Hoffmann-La Roche Ag Indoline derivatives and their use as 5-HT2 receptor ligands
GB0030710D0 (en) 2000-12-15 2001-01-31 Hoffmann La Roche Piperazine derivatives
WO2002051844A1 (en) 2000-12-27 2002-07-04 F. Hoffmann-La Roche Ag Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
GB0106177D0 (en) 2001-03-13 2001-05-02 Hoffmann La Roche Piperazine derivatives
DE60225274T2 (de) 2001-05-21 2009-03-26 F. Hoffmann-La Roche Ag Chinolinderivate als liganden für den neuropeptid-y-rezeptor
US6730319B2 (en) 2001-06-06 2004-05-04 Hoffmann-La Roche Inc. Pharmaceutical compositions having depressed melting points
US20030027786A1 (en) 2001-06-06 2003-02-06 Karsten Maeder Lipase inhibiting composition
US6787558B2 (en) 2001-09-28 2004-09-07 Hoffmann-La Roche Inc. Quinoline derivatives
IL162323A0 (en) * 2001-12-04 2005-11-20 Biogal Pharmaceutical Co Preparation of orlistat and orlistat crystalline forms
GB0202015D0 (en) 2002-01-29 2002-03-13 Hoffmann La Roche Piperazine Derivatives
KR100659428B1 (ko) 2002-02-04 2006-12-19 에프. 호프만-라 로슈 아게 Npy 길항제로서의 퀴놀린 유도체
KR100611854B1 (ko) 2002-02-28 2006-08-11 에프. 호프만-라 로슈 아게 신경 펩타이드 y(npy) 수용체 길항제로서의 티아졸유도체
US7728153B2 (en) * 2002-04-17 2010-06-01 The Burnham Institute For Medical Research Method for the asymmetric synthesis of beta-lactone compounds
AU2003226370A1 (en) * 2002-04-17 2003-11-03 The Burnham Institute Inhibition of fatty acid synthase by beta-lactones and other compounds for inhibition of cellular proliferation
CA2489251A1 (en) 2002-07-05 2004-01-15 F. Hoffmann-La Roche Ag Quinazoline derivatives
EP1539722A1 (en) 2002-08-07 2005-06-15 F. Hoffmann-La Roche Ag Thiazole derivatives
RU2296759C2 (ru) 2002-09-12 2007-04-10 Ф.Хоффманн-Ля Рош Аг N-замещенные 1н-индол-5-пропионовые кислоты, фармацевтическая композиция, содержащая эти соединения, и их применение (варианты)
PL377320A1 (pl) 2002-11-25 2006-01-23 F. Hoffmann-La Roche Ag Pochodne indolilowe
WO2004065346A1 (ja) * 2003-01-21 2004-08-05 Sumitomo Chemical Company, Limited (-)-テトラヒドロリプスタチンおよびその中間体の製造方法
EP1457206A1 (en) * 2003-03-13 2004-09-15 Fournier Laboratories Ireland Limited Combined use of a fibrate and orlistat for the treatment of obesity
WO2004113314A1 (en) * 2003-06-23 2004-12-29 Biocon Limited Novel boronate esters
GB0314967D0 (en) 2003-06-26 2003-07-30 Hoffmann La Roche Piperazine derivatives
EP1651627A2 (en) * 2003-07-15 2006-05-03 Ranbaxy Laboratories Limited Process for preparation of oxetan-2-ones
EP1656374B1 (en) 2003-08-12 2009-03-11 F. Hoffmann-La Roche Ag Thiazole derivatives as npy antagonists
JP2007501823A (ja) 2003-08-12 2007-02-01 エフ.ホフマン−ラ ロシュ アーゲー 2−アミノ−5−ベンゾイルチアゾールなるnpyアンタゴニスト
JP2008540368A (ja) 2005-05-03 2008-11-20 エフ.ホフマン−ラ ロシュ アーゲー 5−ht2リガンドとしての四環式アザピラジノインドリン
JP2009504707A (ja) 2005-08-18 2009-02-05 エフ.ホフマン−ラ ロシュ アーゲー H3受容体調節剤として有用なチアゾリルピペリジン誘導体
US20090171104A1 (en) * 2005-10-05 2009-07-02 Killol Patel Process for the preparation of orlistat
WO2007062999A2 (en) 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 1,5-substituted indol-2-yl amide derivatives
EP1960383B1 (en) 2005-11-30 2010-04-28 F. Hoffmann-la Roche AG 5-substituted indole-2-carboxamide derivatives
WO2007062997A1 (en) 2005-11-30 2007-06-07 F. Hoffmann-La Roche Ag 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators
JP2009518351A (ja) 2005-12-09 2009-05-07 エフ.ホフマン−ラ ロシュ アーゲー 肥満症の処置に有用な三環性アミド誘導体
WO2007068620A1 (en) 2005-12-15 2007-06-21 F. Hoffmann-La Roche Ag Pyrrolo[2,3-c]pyridine derivatives
KR101015666B1 (ko) 2005-12-16 2011-02-22 에프. 호프만-라 로슈 아게 H3 수용체 조절제로서 피롤로[2,3-b]피리딘 유도체
RU2008132966A (ru) * 2006-01-13 2010-02-20 Ф.Хоффманн-Ля Рош Аг (Ch) Производные циклогексилпиперазинилметанона и их применение в качестве модуляторов гистамин н3 рецептора
WO2007082840A1 (en) * 2006-01-23 2007-07-26 F. Hoffmann-La Roche Ag Cyclohexyl sulfonamide derivatives having h3 receptor activity
US7432255B2 (en) 2006-05-16 2008-10-07 Hoffmann-La Roche Inc. 1H-indol-5-yl-piperazin-1-yl-methanone derivatives
CA2652158A1 (en) 2006-05-30 2007-12-06 Matthias Heinrich Nettekoven Piperidinyl pyrimidine derivatives
US7514433B2 (en) 2006-08-03 2009-04-07 Hoffmann-La Roche Inc. 1H-indole-6-yl-piperazin-1-yl-methanone derivatives
US20080146559A1 (en) 2006-12-08 2008-06-19 Li Chen 4,5,6,7-Tetrahydro-Thieno [2,3-C] Pyridine Derivatives
US8680298B2 (en) * 2007-06-06 2014-03-25 Ranbaxy Laboratories Limited Process for the preparation of orlistat
EP2183237A1 (en) 2007-07-25 2010-05-12 F. Hoffmann-Roche AG Benzofuran- and benzo[b]thiophene-2-carboxylic acid amide derivatives and use thereof as histamine 3 receptor modulators
KR101076680B1 (ko) * 2007-11-01 2011-10-26 한미홀딩스 주식회사 (6r)-3-헥실-4-히드록시-6-운데실-5,6-다이히드로피란-2-온의 제조방법 및 이에 사용되는 중간체
CN105384636B (zh) * 2015-11-17 2017-12-26 湖南尔康制药股份有限公司 一种柠檬酸酯的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2023604B (en) * 1978-05-25 1982-07-28 Microbial Chem Res Found Physiologically active derivatives of esterastin and production thereof
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
CA1328881C (en) * 1984-12-21 1994-04-26 Pierre Barbier Process for the manufacture of oxetanones
CA1270837A (en) * 1984-12-21 1990-06-26 Hoffmann-La Roche Limited Oxetanones

Also Published As

Publication number Publication date
CN85109209A (zh) 1986-09-17
IE58917B1 (en) 1993-12-01
EP0189577B1 (de) 1989-12-13
DE3574700D1 (de) 1990-01-18
AU5125885A (en) 1986-06-26
ATE48600T1 (de) 1989-12-15
IE853276L (en) 1986-06-21
EP0189577A3 (en) 1987-05-06
DK592585D0 (da) 1985-12-19
AU585555B2 (en) 1989-06-22
NZ214567A (en) 1990-01-29
CN1010586B (zh) 1990-11-28
US4983746A (en) 1991-01-08
DK168536B1 (da) 1994-04-18
EP0189577A2 (de) 1986-08-06
PH22445A (en) 1988-09-12
CA1328881C (en) 1994-04-26

Similar Documents

Publication Publication Date Title
DK592585A (da) Fremgangsmaade til fremstilling af oxetanoner
ATE54938T1 (de) Verfahren zur reinigung des japanischen enzephalitisvirus.
GB1393545A (en) Unsaturated phosphate esters useful in forming coatings
BR7908473A (pt) Processo de depuracao de gas acido
DK630988A (da) Fremgangsmaade til fremstilling af delta1,4-3-keto-21-hemiester-steroider
OA06490A (fr) Procédé de purification de l'acide phosphorique.
AT336148B (de) Verfahren zur herstellung verbesserter, durch elektronenstrahlung hartbarer uberzugsmittel
AU7674881A (en) Hydroxycyanomethylphosphonic acid
ATE1142T1 (de) Verfahren zur herstellung von methylen-bis-(4-phenyl-carbaminsaeureester).
BR8000385A (pt) Processo de purificacao de um acido fosforico impuro
BR7900447A (pt) Processo de preparacao de tris(hidroximetil)aminometano
SE7601948L (sv) Sett att framstella karboxi-alkan-fosfonsyror och karboxi-alkyl-fosfinsyror
GB2012756A (en) Preparation of 5-arylhydantoins
ES8307236A1 (es) Un procedimiento para la preparacion de ranitidina.
ES483249A1 (es) Procedimiento para la obtencion de diciclopentilen(2,2'-bis (4-alquil-6-t-butilfenoles).
SE8002295L (sv) Forbettrat forfarande for framstellning av 3-0-demetylfortimiciner
ATE9477T1 (de) Verfahren zur herstellung von 1,1'-diacetalen.
SE7903828L (sv) 1,6-dimesyl-3,4-dimetyl-d-mannitol jemte sett for dess framstellning
JPS5212129A (en) Process for preparation of fluorocarbonvinylether
DK354883A (da) Fremgangsmaade til inversion af konfigurationen hos optisk aktive forbindelser samt optisk aktive mellemprodukter ved denne fremgangsmaade
DK497483D0 (da) Fremgangsmade og mellemprodukter til fremstilling af 1,1-dioxopenicillanoyloxymethyl-6-beta-aminopenicillanat
DE2961007D1 (en) Process for manufacture of corrosion-resistant coatings
DK342383A (da) Fremgangsmaade til fremstilling af 4-amino-5-dialkoxymethylpyrimidinderivater
ES481479A1 (es) Procedimiento para la preparacion de esteres dialcohilicos de acidos n-ciano-ditioimidocarbonicos.
JPS56169664A (en) Preparation of nitrile

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment
AHS Application shelved for other reasons than non-payment
B1 Patent granted (law 1993)
PUP Patent expired